China’s Diagnosis and Treatment Guidelines for Primary Liver Cancer (2022), issued by the National Health Commission, recommends combining AFP-L3 and DCP to improve the diagnosis rate of early HCC. The gene discussed is AFP; the disease is liver cancer.